Actinium Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.98

-0.01 (-1.01%)

As of Jun 30, 10:43 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 2 18%

Sell 0 0%

Price Target

Analyst Price Target +3,584.7% upside

Low Target $23.47

Average Target $36.11

High Target $39.96

Current Price $0.98

Current
$0.98

Target
$36.11

$23.47 $36.11 avg $39.96

Scenario Analysis

Bear Case

$23.47

2,294.9%

Low target

Base Case

$36.11

+3,584.7%

Avg target

Bull Case

$39.96

+3,977.6%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.89

-48.1% from high

52-Week Low

$0.94

+4.3% from low

Target vs 52W High

$36.11

+1,810.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%